PH
PharmaTher Holdings Ltd.
PHRM.CN · CNQ
$0.07 +18.18% (+$0.01)
1M +30.00%
Market Cap $5.92M
P/E Ratio -
Div. Yield -
ROE 98.98%
Bulios Fair Price
$0.05
23.1% downside
Current Price
$0.065
Undervalued Fair Value Overvalued
According to Bulios Fair Price, PHRM.CN is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/B 9.65x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 51.63%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 137.98%
ROE 98.98%
ROA 54.39%
Debt
97 /100
Low Debt/Equity 0.00x
Current ratio 1.83x
Int. coverage N/A
Stability
44 /100
Moderate Beta 2.34x
EPS volatility 5.57%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about PHRM.CN
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Fabio Chianelli
Employees
8
Headquarters
Toronto
Upcoming events
28 OCT
Earnings
Upcoming earnings report